Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 996Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2AstraZeneca Canada Inc.

02 2Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

Meropenem

Brand Name : MERREM

Patent Number : 1322371

Filing Date : 1987-07-29

Strength per Unit : 500mg

Dosage Form : sterile powder for I.v. or I.m. use

Human Or VET : Human

Route of Administration : intravenous, intramuscular

Patent Expiration Date : 2010-09-21

Date Granted : 1993-09-21

blank

02

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

Meropenem

Brand Name : MERREM

Patent Number : 1322371

Filing Date : 1987-07-29

Strength per Unit : 1000mg

Dosage Form : sterile powder for I.v. or I.m use

Human Or VET : Human

Route of Administration : Intravenous, intramuscular

Patent Expiration Date : 2010-09-21

Date Granted : 1993-09-21

blank

03

arrow
American Pharma Summit
Not Confirmed

Country
arrow
American Pharma Summit
Not Confirmed

Meropenem

Brand Name :

Patent Number : 1283906

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-05-07

Date Granted :

blank

04

arrow
American Pharma Summit
Not Confirmed

Country
arrow
American Pharma Summit
Not Confirmed

Meropenem

Brand Name :

Patent Number : 1283906

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-05-07

Date Granted :

blank